When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...

Good morning, ladies and gentlemen, and welcome to the Humacyte Third Quarter 2024 Results Conference Call. Currently, all participants are in a listen-only mode. Later, we will conduct a question-and ...

Novo Nordisk's stock has dropped to $110 per share, but operational performance remains strong. See why I believe we are at ...

Additionally, U.S. sales also contributed positively by surpassing consensus ... The firm engages in the development, manufacture and marketing of an insulin infusion system for people with ...

The S&P 500 added 0.4% on Friday, Nov. 8, posting its highest-ever close to end a momentous week that included an election ...

Insulet saw strong insulin pump adoption among new users with Type 2 diabetes following its recent FDA clearance, while ...

Insulet (Nasdaq:PODD) shares ticked up today on third-quarter results that came in well ahead of the consensus forecast.

Insulet raised its annual revenue growth forecast on Thursday, banking on strong demand for its wearable insulin pumps.

Coca-Cola contains almost 35g of (added) sugar in a 330ml can – almost nine teaspoons. A 500ml can of Monster Energy Drink weighs in at a tooth-aching 55g of sugar – almost 14 teaspoons. Drinking just ...

Tandem Diabetes Care shares ticked up after hours today on third-quarter results that topped the consensus forecast.

Tandem Diabetes Care (TNDM) and Insulet (PODD) stocks draw outperform ratings at Bernstein as insulin pump makers prepare for ...

Novo Nordisk's Q3 2024 report highlights a 21% YoY sales increase with strong gains in GLP-1 diabetes and obesity drugs but ...